Publications
Maintenance of bone resorption markers in the low premenopausal range during the year following denosumab discontinuation is associated to bone density preservation. The ReoLaus study.
Liebich G, Lamy O, Aubry-Rozier B, Gonzalez-Rodriguez E
Bone. 2023 Jul;172:116764
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Disease
Shevroja E, Reginster JY, Lamy O, Al-Daghri N, Chandran M, Demoux-Baiada AL, Kohlmeier L, Lecart MP, Messina D, Camargos BM, Payer J, Tuzun S, Veronese N, Cooper C, McCloskey EV, Harvey NC
Osteoporos Int. 2023 Jul 1
Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
Métrailler A, Hans D, Lamy O, Gonzalez Rodriguez E, Shevroja E
Osteoporos Int. 2023 May 8
FRAX Adjustment by Trabecular Bone Score with or Without Bone Mineral Density: The Manitoba BMD Registry.
Leslie WD, Binkley N, McCloskey EV, Johansson H, Harvey NC, Lorentzon M, Kanis JA, Hans D
J Clin Densitom. 2023 Apr 26:101378
Updated trabecular bone score accounting for the soft tissue thickness (TBS(TT)) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.
Hans D, Shevroja E, McDermott M, Huang S, Kim M, McClung M
Osteoporos Int. 2022 Dec;33(12):2517-2525
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.
Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C, Al-Daghri N, Bock O, Bruyère O, Rosa MM, Cortet B, Cruz-Jentoft AJ, Cherubini A, Dawson-Hughes B, Fielding R, Fuggle N, Halbout P, Kanis JA, Kaufman JM, Lamy O, Laslop A, Yerro
Aging Clin Exp Res. 2022 Nov;34(11):2603-2623
Bone Texture Assessment on Lateral VFAs Using the Texture Research Investigational Platform (TRIP) and its Fracture Discrimination Ability.
Shevroja E, White R, Lamy O, Krueger D, Hans D, Binkley N
J Clin Densitom. 2022 Oct-Dec;25(4):599-605
The fracture predictive ability of lumbar spine BMD and TBS as calculated based on different combinations of the lumbar spine vertebrae.
Shevroja E, Mo Costabella F, Gonzalez Rodriguez E, Lamy O, Hans D
Arch Osteoporos. 2022 Jun 9;17(1):83
Management of patients at very high risk of osteoporotic fractures through sequential treatments.
Curtis EM, Reginster JY, Al-Daghri N, Biver E, Brandi ML, Cavalier E, Hadji P, Halbout P, Harvey NC, Hiligsmann M, Javaid MK, Kanis JA, Kaufman JM, Lamy O, Matijevic R, Perez AD, Radermecker RP, Rosa MM, Thomas T, Thomasius F, Vlaskovska M, Rizzoli R, Coo
Aging Clin Exp Res. 2022 Apr;34(4):695-714
Association of adiposity evaluated by anthropometric, BIA, and DXA measures with cardiometabolic risk factors in nonobese postmenopausal women: the CoLaus/OsteoLaus cohort.
Stamm E, Marques-Vidal P, Rodriguez EG, Vollenweider P, Hans D, Lamy O
Menopause. 2022 Jan 24;29(4):450-459
Quantitative Ultrasound (QUS) in the Management of Osteoporosis and Assessment of Fracture Risk: An Update.
Hans D, Métrailler A, Gonzalez Rodriguez E, Lamy O, Shevroja E
Adv Exp Med Biol. 2022;1364:7-34
Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
Vendrami C, Marques-Vidal P, Gonzalez Rodriguez E, Hans D, Waeber G, Lamy O
Osteoporos Int. 2022 Jan;33(1):195-204
Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.
Gonzalez Rodriguez E, Marques-Vidal P, Aubry-Rozier B, Papadakis G, Preisig M, Kuehner C, Vollenweider P, Waeber G, Hans D, Lamy O
Calcif Tissue Int. 2021 Nov;109(5):499-509
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases.
Burckhardt P, Faouzi M, Buclin T, Lamy O, The Swiss Denosumab Study Group
J Bone Miner Res. 2021 Sep;36(9):1717-1728
Machine Learning Solutions for Osteoporosis-A Review.
Smets J, Shevroja E, Hügle T, Leslie WD, Hans D
J Bone Miner Res. 2021 May;36(5):833-851
Evolution in fracture risk assessment: artificial versus augmented intelligence.
Hans D, Shevroja E, Leslie WD
Osteoporos Int. 2021 Feb;32(2):209-212
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO).
Ferrari S, Lippuner K, Lamy O, Meier C
Swiss Med Wkly. 2020 Sep 21;150:w20352
Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.
Lanyan A, Marques-Vidal P, Gonzalez-Rodriguez E, Hans D, Lamy O
Osteoporos Int. 2020 May;31(5):875-886
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
Gonzalez-Rodriguez E, Aubry-Rozier B, Stoll D, Zaman K, Lamy O
Breast Cancer Res Treat. 2020 Jan;179(1):153-159
Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.
Shevroja E, Aubry-Rozier B, Hans G, Rodriguez EG, Stoll D, Lamy O, Hans D
J Bone Miner Res. 2019 Dec;34(12):2229-2237
The Metabolic Benefits of Menopausal Hormone Therapy Are Not Mediated by Improved Nutritional Habits. The OsteoLaus Cohort.
Papadakis GE, Hans D, Gonzalez Rodriguez E, Vollenweider P, Waeber G, Marques-Vidal P, Lamy O
Nutrients. 2019 Aug 16;11(8)
[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]
Gonzalez Rodriguez E, Lamy O, Aubry-Rozier B, Stoll D, Uebelhart B
Rev Med Suisse. 2019 Apr 17;15(647):831-835
Stopping Denosumab.
Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG
Curr Osteoporos Rep. 2019 Feb;17(1):8-15
Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort.
Papadakis GE, Hans D, Rodriguez EG, Vollenweider P, Waeber G, Marques-Vidal P, Lamy O
J Clin Endocrinol Metab. 2018 May 1;103(5):1948-1957
Quand le silence prend patients, médecins et assureurs-maladie à contre-pied
Lamy, O.
In Forum Médical Suisse (Vol. 18, No. 08, pp. 167-167). EMH Media.
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
Aubry-Rozier B, Stoll D, Gonzalez Rodriguez E, Hans D, Prudent V, Seuret A, Farron A, Lamy O
Swiss Med Wkly. 2018;148:w14579
Rue du Bugnon 46
1011 Lausanne
+41 21 314 9548
Rue du Bugnon 46
1011 Lausanne
+41 21 314 9548